“Identifying therapeutic targets to prevent progression of familial RUNX1 disorder to AML using novel iPSC models.” - PROJECT COMPLETED

Dr. Papapetrou’s lab aims to develop an iPSC-based model of progression of familial RUNX1 disorder with the goal of identifying therapeutic targets to prevent leukemia progression.